TickerFacts.

Citius Oncology, Inc. (CTOR): Shareholders' Equity

Annual figures by period end, from SEC filings.

$44.87M
As of 2025-09-30
$40.38M
As of 2026-06-30
$46.14M2021-12-31: -$10.1K2022-12-31: $345.5K2023-09-30: $25.54M2023-12-31: -$1.99M2024-09-30: $46.14M2025-09-30: $44.87M$44.87M
2021-12-31 Shareholders' Equity (USD) 2025-09-30
Period endedShareholders' EquityChange YoYSource filing
2025-09-30$44.87M-2.8%2025-12-23, Balance as of period end
2024-09-30$46.14Mn/a2025-12-23, Balance as of period end
2023-12-31-$1.99Mn/a2024-04-16, Balance as of period end
2023-09-30$25.54Mn/a2024-12-27, Balance as of period end
2022-12-31$345.5Kn/m2024-04-16, Balance as of period end
2021-12-31-$10.1Kn/a2023-04-17, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Citius Oncology, Inc. (CTOR)2025-09-30$44.87M-2.8%
iBio, Inc. (IBIO)2026-06-30$85.71M+476.0%
Minerva Neurosciences, Inc. (NERV)2025-12-31-$140.75Mn/m
Tenax Therapeutics, Inc. (TENX)2025-12-31$97.07M+5.5%
Immix Biopharma, Inc. (IMMX)2025-12-31$93.80M+607.8%
Aytu Biopharma, Inc (AYTU)2026-06-30$35.27M+86.0%
Celularity Inc (CELU)2025-12-31-$38.06Mn/m
Arbutus Biopharma Corp (ABUS)2025-12-31$76.58M-21.4%
Journey Medical Corp (DERM)2025-12-31$31.85M+58.7%

Compare CTOR, IBIO, NERV, TENX side by side · Screen every company in Pharmaceutical Preparations ↗